2005
DOI: 10.1111/j.1468-1293.2005.00282.x
|View full text |Cite
|
Sign up to set email alerts
|

In the era of highly active antiretroviral therapy, why are HIV‐infected patients still admitted to hospital for an inaugural opportunistic infection?

Abstract: ObjectivesTo identify factors related to delayed testing, and delayed or interrupted care-seeking or treatment uptake, among HIV-infected patients. DesignHIV-infected patients hospitalized for an opportunistic infection (OI) cases were included in a prospective study and compared with controls matched by age and sex who had regular follow-up and treatment. Patients were asked to complete a questionnaire about their therapeutic itinerary and their socioeconomic, psychological and medical characteristics. Result… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
14
1
5

Year Published

2009
2009
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(20 citation statements)
references
References 29 publications
0
14
1
5
Order By: Relevance
“…Despite considerable advances in the treatment and management of HIV-1 disease, certain infections still present a significant clinical challenge particularly among HIV-infected individuals who are diagnosed at advanced stages, those who lack access to antiretroviral therapy, and those who cannot maintain adherence to therapy and clinical care. [18][19][20] This includes an increased risk of developing bacterial pneumonia even in HIV-1-infected patients with relatively normal CD4 counts, 21 indicating that impaired CD4 T-cell independent control of certain infections still exists even in the context of treated HIV-1 disease. Mucosal-associated invariant T (MAIT) cells are a relatively recently discovered subset of unconventional, innate-like T cells that are highly abundant in mucosal tissues, liver, and peripheral blood.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Despite considerable advances in the treatment and management of HIV-1 disease, certain infections still present a significant clinical challenge particularly among HIV-infected individuals who are diagnosed at advanced stages, those who lack access to antiretroviral therapy, and those who cannot maintain adherence to therapy and clinical care. [18][19][20] This includes an increased risk of developing bacterial pneumonia even in HIV-1-infected patients with relatively normal CD4 counts, 21 indicating that impaired CD4 T-cell independent control of certain infections still exists even in the context of treated HIV-1 disease. Mucosal-associated invariant T (MAIT) cells are a relatively recently discovered subset of unconventional, innate-like T cells that are highly abundant in mucosal tissues, liver, and peripheral blood.…”
Section: Introductionmentioning
confidence: 99%
“…Despite considerable advances in the treatment and management of HIV-1 disease, certain infections still present a significant clinical challenge particularly among HIV-infected individuals who are diagnosed at advanced stages, those who lack access to antiretroviral therapy, and those who cannot maintain adherence to therapy and clinical care. [18][19][20] This includes an increased risk of developing bacterial pneumonia even in HIV-1-infected patients with relatively normal CD4 counts, 21 indicating that impaired CD4 T-cell independent controlthe expression of CD161, the IL-18 receptor (IL-18R), and the transcription factor ZBTB16, also known as PLZF. [26][27][28] The majority of MAIT cells are CD8 ϩ , expressing either CD8␣␣ or CD8␣␤, with minor CD4 ϩ or CD8/4 double-negative populations.…”
Section: Introductionmentioning
confidence: 99%
“…Other patients who present with opportunistic infections are those who are aware of their illness but fail to receive adequate treatment and care [271,272]. Reasons for this may include psychosocial and socioeconomic factors, such as increasing copayments for medications that cannot be afforded by low income groups in addition to higher bureaucratic hurdles that have been set up by some healthcare providers that exclude patients with lower educational status, migratory background and/or older patients with dementia who might not be able to comply with the required documentation to receive the benefits, even in developed countries such as Germany, among others [269,270].…”
Section: Therapy Of CMV End-organ Disease In Hiv Infectionmentioning
confidence: 99%
“…Despite the successful introduction of HAART in the USA and western Europe, a substantial proportion of HIV-infected individuals in these countries are not aware of their infection and present late in their disease with substantially decreased CD4 + T-cell counts and similar patterns of opportunistic infections as compared with the pre-HAART area (so-called 'late presenter') [267][268][269][270]. In these patients Pneumocystis jirovecii is the most frequent manifestation; however, CMV end-organ diseases causes a significant morbidity in this population similar to that in the early epidemic [67].…”
Section: Therapy Of CMV End-organ Disease In Hiv Infectionmentioning
confidence: 99%
“…1,2,3,4,5 However, despite a national HCT campaign from 2010 to 2012 in South Africa, only 50.6% of youth aged 15-24 years reported testing, compared with 78.2% of adults aged 25-49 years. 6 As part of the national HCT campaign, the South African Departments of Basic Education and Health announced that they intended to launch an HCT campaign specifically targeting secondary school students.…”
Section: Introductionmentioning
confidence: 99%